ReviewGenome medicine2019
The good, the bad, and the ugly: hyperprogression in cancer patients following immune checkpoint therapy.
Erich Sabio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it